Previously, we determined C5a levels in longitudinally collected serum samples from 49 patients suffering from C-19 with different clinical intensities and concluded that serum C5a levels remain high in severe cases of COVID-19 and are associated with the persistence of respiratory symptoms after hospital discharge (4). The gene discussed is C5; the disease is COVID-19.